Stocktoria
ARROWHEAD PHARMACEUTICALS, INC. ARWR
ARROWHEAD PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 15,683,206 | $407.6M | 11.56% |
| D. E. Shaw & Co., Inc. | 1,192,838 | $74.8M | 0.88% |
| RENAISSANCE TECHNOLOGIES LLC | 1,036,495 | $65.0M | 0.76% |
| CITADEL ADVISORS LLC | 350,494 | $22.0M | 0.26% |
| AQR CAPITAL MANAGEMENT LLC | 167,210 | $10.3M | 0.12% |
| Bridgewater Associates, LP | 95,552 | $6.0M | 0.07% |
| Point72 Asset Management, L.P. | 46,400 | $2.9M | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 45,700 | $2.9M | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.